Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.

Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation. Blood (2011) 2.27

Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay. Mol Cell Proteomics (2011) 1.40

New mechanisms of antiplatelet activity of nifedipine, an L-type calcium channel blocker. Biomedicine (Taipei) (2014) 0.83

Activation of the cGMP/Protein Kinase G Pathway by Nitric Oxide Can Decrease TRPV1 Activity in Cultured Rat Dorsal Root Ganglion Neurons. Korean J Physiol Pharmacol (2012) 0.80

Vascular thiol isomerases. Blood (2016) 0.78

Inhibitory role of S-nitrosoglutathione in the aggregation of frozen platelets, and its effect on the expression of membrane glycoproteins. Exp Ther Med (2013) 0.77

Small Diameter Blood Vessels Bioengineered From Human Adipose-derived Stem Cells. Sci Rep (2016) 0.75

Current knowledge on the mechanism of atherosclerosis and pro-atherosclerotic properties of oxysterols. Lipids Health Dis (2017) 0.75

Platelet Ca(2+) responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary activation of P2X1 receptors and release from intracellular Ca(2+) stores. Blood (2012) 1.49

Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade. Blood (2010) 1.07

Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways. Blood (2013) 0.93

cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway. Blood (2013) 0.93

Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis (2004) 0.91

Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease. FEBS J (2007) 0.89

Prednisolone exerts exquisite inhibitory properties on platelet functions. Biochem Pharmacol (2012) 0.87

The role of protein nitration in the inhibition of platelet activation by peroxynitrite. FEBS Lett (2002) 0.84

Nitric oxide at a glance. Platelets (2010) 0.83

cGMP-independent inhibition of integrin alphaIIbbeta3-mediated platelet adhesion and outside-in signalling by nitric oxide. FEBS Lett (2007) 0.81

Inhibition of ADP-induced platelet adhesion to immobilised fibrinogen by nitric oxide: evidence for cGMP-independent mechanisms. Biochem Pharmacol (2007) 0.81

The nitration of proteins in platelets: significance in platelet function. Free Radic Biol Med (2002) 0.80

Sodium orthovanadate induced tyrosine phosphorylation of platelet nitric oxide synthase negatively regulates enzyme activity. Biochim Biophys Acta (2006) 0.80

Compartmentalisation of cAMP-dependent signalling in blood platelets: The role of lipid rafts and actin polymerisation. Platelets (2014) 0.79

Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein VI mediates platelet nitric oxide synthesis in response to collagen. Thromb Haemost (2005) 0.79

Morbidity and mortality factors in key deer (Odocoileus virginianus clavium). J Wildl Dis (2002) 0.78

Peroxynitrite causes phosphorylation of vasodilator-stimulated phosphoprotein through a PKC dependent mechanism. Platelets (2010) 0.76

The nitration of platelet vasodilator stimulated phosphoprotein following exposure to low concentrations of hydrogen peroxide. Platelets (2008) 0.76

Acute hypertriglyceridemia induces platelet hyperactivity that is not attenuated by insulin in polycystic ovary syndrome. J Am Heart Assoc (2014) 0.75

Platelet membrane CD154 and sCD154 in progressive peripheral arterial disease: a pilot study. Atherosclerosis (2006) 0.75